Sage Therapeutics Inc (SAGE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SAGE Annual Balance Sheets →
Quarterly balance sheet trends provide context on Sage Therapeutics Inc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2025)
(Mar 31 2025) (Dec 31 2024) (Sep 30 2024) (Jun 30 2024)
Assets
Cash & cash equivalent67.49
Restricted Cash and Cash Equivalents, Current0.00
Marketable Securities, Current SH298.09
Cash & Short-term Investments365.00
Accounts receivable16.27
Other Receivables, Net, Current8.11
Prepaid Expense And Other Assets Current19.14
Total Current Assets409.09
Equipment/Property/Plant Net0.67
Long-term investments1.45
Other Assets, Noncurrent3.00
Operating Lease Right Of Use Asset9.96
Total Assets422.92
Liabilities
Accounts Payable, Current AC0.69
Accrued Liabilities, Current AC42.07
Other Liabilities, Current1.88
Total Current Liabilities44.64
Total Long-term Debt0.00
Other liabilities, Noncurrent9.54
Operating Lease Liability Current1.88
Operating Lease Liability Noncurrent9.54
Total Liabilities54.19
Stockholders' Equity
Treasury Stock Common Value-0.40
Common Stock Value0.01
Additional Paid In Capital Common Stock3,451.31
Retained Earnings / Accumulated Deficit-3,082.19
Other Equity0.02
Common Stockholder's Equity368.74
Total Stockholder's Equity368.74
Liabilities & Stockholder's Equity422.92
4 historic quarters locked

Sign in to unlock the full Sage Therapeutics Inc balance sheet history.

About Sage Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-100276

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.